| Title |
Treatment of adults with attention-deficit/hyperactivity disorder
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, March 2008
|
| DOI | 10.2147/ndt.s1747 |
| Pubmed ID | |
| Authors |
Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman |
| Abstract |
This review focuses on the treatment of attention deficit hyperactivity disorder (ADHD) in adults. It briefly addresses prevalence, diagnostic and differential diagnostic issues specific to adults. Stimulant medication, non-stimulant medication, and psychosocial treatments are thoroughly reviewed. For each class of medication possible mechanism of action, efficacy and side effects are summarized. Special attention is given to the pharmacological treatment for patients with adult ADHD and various comorbidities. In summary, stimulant medications are most effective and combined medication and psychosocial treatment is the most beneficial treatment option for most adult patients with ADHD. |
Mendeley readers
The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Germany | 1 | <1% |
| Canada | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 111 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 16% |
| Student > Bachelor | 18 | 16% |
| Student > Ph. D. Student | 17 | 15% |
| Student > Master | 16 | 14% |
| Student > Doctoral Student | 11 | 9% |
| Other | 19 | 16% |
| Unknown | 17 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 34 | 29% |
| Psychology | 23 | 20% |
| Agricultural and Biological Sciences | 7 | 6% |
| Social Sciences | 7 | 6% |
| Nursing and Health Professions | 6 | 5% |
| Other | 17 | 15% |
| Unknown | 22 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2020.
All research outputs
#1,586,813
of 25,808,886 outputs
Outputs from Neuropsychiatric Disease and Treatment
#201
of 3,150 outputs
Outputs of similar age
#3,814
of 96,534 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 29 outputs
Altmetric has tracked 25,808,886 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,150 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,534 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.